Study of EZN-2208 Pediatric Patients With Solid Tumors
Clinical trial NCT01295697 · TERMINATED
Trial details
- NCT number
- NCT01295697
- Sponsor
- Enzon Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.